Literature DB >> 1534576

Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.

R J Di Rocco1, W L Rumsey, B L Kuczynski, K E Linder, J P Pirro, R K Narra, A D Nunn.   

Abstract

We have compared apparent myocardial blood flow (MBFapparent) indicated by 99mTc-teboroxime, 96Tc-sestamibi and 201TI to true MBF indicated by radiolabeled microscopheres using a technique for the co-injection of four radionuclides in the same animal. Studies were performed using rats in a single-pass model to obtain global MBF and using dogs in a multiple-pass model to determine regional MBF. To provide a wide range of MBF, adenosine was administered intravenously and the left anterior descending coronary artery was then ligated in the dogs, or hypercapnia was induced by decreasing respiratory frequency in the rats. The microsphere formula for determining MBF was applied to all agents. When MBFapparent was plotted as a function of true MBF, the ability of each agent to measure changes in true MBF was demonstrated by the proximity of the plotted function to the line of identity. For both the single and multiple-pass studies, statistical analysis of the nonlinear relationship between MBFapparent and true MBF showed that 201TI and 99mTc-teboroxime approximate true MBF better than 96Tc-sestamibi (p less than 0.001) under the conditions used in the present studies. In the single-pass studies, 99mTc-teboroxime approximated true MBF better than 201Tl (p less than 0.05), but in the multiple-pass experiments, 201Tl approximated true MBF better than 99mTc-teboroxime in only one dog (p less than 0.01) with no difference in the other two. Determination of the permeability-surface area product, PS, for each agent shows that the higher fidelity to true MBF obtained with 201Tl and 99mTc-teboroxime is related to substantially greater PS values for these agents relative to 96Tc-sestamibi.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534576

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination.

Authors:  A M Smith; G T Gullberg; P E Christian
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

2.  Technetium 99m-labeled teboroxime: death in utero, infanticide, or failure to thrive?

Authors:  R J Burns
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

3.  Myocardial blood flow quantification with SPECT and conventional tracers: a critical appraisal.

Authors:  Stephan G Nekolla; Christoph Rischpler; Kenichi Nakajima
Journal:  J Nucl Cardiol       Date:  2014-10-04       Impact factor: 5.952

4.  Compartmental modeling of technetium-99m-labeled teboroxime with dynamic single-photon emission computed tomography: comparison with static thallium-201 in a canine model.

Authors:  E V Di Bella; S G Ross; D J Kadrmas; H S Khare; P E Christian; S McJames; A G Gullberg
Journal:  Invest Radiol       Date:  2001-03       Impact factor: 6.016

5.  Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis.

Authors:  S Maurea; A Cuocolo; L Pace; E Nicolai; A Nappi; M Imbriaco; C Morisco; M Chiariello; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-06

6.  SPECT Imaging of Teboroxime during Myocardial Blood Flow Changes.

Authors:  E V R Di Bella; H S Khare; D J Kadrmas; G T Gullberg
Journal:  IEEE Trans Nucl Sci       Date:  2000-06       Impact factor: 1.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.